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The purpose of this report is to present recent data on two modulating factors of carcinogenesis that
are found in Western-type diets: a beef-derived mutagenesis modulator that has been shown to inhibit the
initiation of epidermal carcinogenesis in mice, and the possible role of net energy rather than dietary fat
per se in the enhancement of rat mammary carcinogenesis.
Introduction
It is well established that foods contain substances
that can initiate and/or enhance carcinogenesis as well
as substances that can inhibit carcinogenesis (1-3). In
fact, it would be virtually impossible to consume a diet
devoid of carcinogens and enhancers or inhibitors of
carcinogenesis. The full implication of this observation
in terms of human health is not yet known, but it is
possible that the balance between opposing factors in
the diet is of greater importance than the presence of
any single factor per se (4).
The purpose of this report is to present our recent
findings with regard to two modulating factors found in
Western-type diets: first, a beef-derived mutagenesis
modulator that has been shown to inhibit the initiation
of epidermal carcinogenesis in mice, and second, the
role of net energy rather than dietary fat per se in the
enhancement of mammary carcinogenesis in rats.
Results
Beef-Derived Mutagenesis Modulator
Previously we reported that methylene chloride ex-
tracts of fried ground beef contained a mutagenesis
modulator as well as bacterial mutagens (4,5). Similar,
possibly identical activity was also detected in extracts
of uncooked ground beef. The mutagenesis modulator
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was not toxic for the bacteria under the conditions of
test, and appearedto actontheratliverS-9preparation
(9OOg supernatant) added to the system to activate the
mutagens for mutagenesis. Depending upon the type of
rat liver S-9 (uninduced, or induced with phenobarbital
orAroclor 1254) and themutagenundertest, inhibition,
enhancement, orno effect onmutagenesis was observed
(5).
Three mutagenesis modulator preparations were
tested, and they are identified as preparations A, B,
and C. PreparationAwasextractedusingamodification
(6) of the method of Bjeldanes et al. (7) designed to
extract the heterocyclic amine mutagens from fried
ground beef. However, partially purified modulator
preparations are not soluble in water (6), and for this
reason the Bjeldanes et al. method (7) is not suitable
for efficient extraction ofthe modulatoractivity. There-
fore, a more efficient method based on extraction with
acetonitrile was developed (6). Preparation B was ex-
tracted with acetonitrile using the method described
above (6). Preparation C was obtained by further pu-
rification ofpreparation B by using column chromatog-
raphy (6).
Figure 1 demonstrates that the modulator activity
extracted fromfried ground beefinhibits 7,12-dimethyl-
benz[a]anthracene (DMBA) mutagenesis in Salmonella
typhimurium TA 98 mediated by liver S-9 from phen-
obarbital-treated rats. The inhibitory effect is due to a
decrease in mutagenesis rather than to bacterial tox-
icity. The data also indicate that the extraction method
developed specifically forthe modulator (preparation B,
Fig. 1B) extracts the modulator more efficiently than
the method developed for mutagen extraction (Prepa-












FIGURE 1. Inhibition ofrat liver S-9 mediated DMBA mutagenesis
by three different preparations ofmodulator. The control (DMBA
without modulator) for each experiment is indicated on the ab-
scissa by the letter C.Salmonella typhimurium TA 98 was used
and the background (20-30 colonies) was subtracted from all data
prior to analysis. (A) preparation A, data presented as mean ±
SEM where the SEM is larger than the symbol. Assays were
conducted in triplicate except for the control where 6 replicates
were performed. Because of limited material, toxicity was as-
sessed by examining the bacterial lawn, which appeared normal
on all plates. The amount of modulator tested in this experiment
was not precisely quantified and is therefore given as gram-equiv-
alents of original ground beef starting material. (B) preparation
B, data presented as means ofduplicate determinations except for
the control forthemutagenesis assay, wherethree determinations
were performed and the result plotted as the mean +/- SEM.
The specific activity of this preparation (based on that amount
necessary to inhibit mutagenesis by 50%, which is defined as one
unit) (6) was calculated to be 9.5 units/mg. (C) preparation C, data
presented as means of duplicate assays. The specific activity of
this preparation was calculated to be 31 units/mg (6).
ulator activity extracted from 100 g ground beefusing
the preparation Amethod inhibited mutagenesisby70%
(Fig. 1A). In contrast, 0.5 mg of preparation B which
by extrapolation (6) was derived from just 0.5 g of
ground beef (weight before frying) was sufficient to in-
hibit mutagenesis by 90% (Fig. 1B).
We have also found that the modulator is insoluble in
water, 1.2 N HCI, and 2.5 N NaOH, but soluble and
stable in concentrated H2SO4. These solubility prop-
erties appear to eliminate several possible molecular
structures, for example, proteins, peptides, charged or
polar lipids, carbohydrates, molecules with five carbons
orless, phenols orpolyhydroxy phenols, hydroxy acids,
amino acids, amides, amines, acids or anhydrides (6,8).
The solubility in organic solvents, notably hexane, in-
dicates that it is a very nonpolar molecule, a conclusion
supported by its behavior on column chromatography
(6). It remains possible that the modulator activity is
effected by a class of closely related compounds.
Figure 2 shows that all three modulator preparations
inhibited the initiation of mouse epidermal tumors by
DMBA. The modulator-treated mice consistently ex-
hibited fewer papillomas and lower papilloma inci-
dences. Moreover, some modulator-treated mice were
completely protected from the carcinogenic effects of
DNBA during the experimental period and beyond.
Each experiment began with two groups of 20 mice,
except for the modulator-treated group in Figure 2A,
where 17 mice were used. The mouse tumor assay sys-
tem employed was based on a report ofSlaga and Bout-
well (9). Female SENCAR (10) or CD-1 mice were
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FIGURE 2. Inhibition of initiation of mouse epidermal tumors by
three different preparations ofmodulator: (e) positive control; (0)
modulator-treated mice (6).
acetone alone (controls). Five minutes later (except
where otherwise specified) an initiating dose of DMBA
(10 nmole/mouse for SENCAR mice; 50 nmole/mouse
for CD-1 mice) in 0.2 mL acetone was applied. One to
two weeks later, twice weekly applications of TPA (2
iLg/mouse for SENCAR mice; 6 ,ug/mouse for CD-1
mice) in 0.2 mL acetone was commenced and continued
for the remainder of the experiments. The three ex-
periments reported were conducted independently at
different times. For positive control versus modulator-
treated mice, the means ofpapillomas per mouse prep-
aration for A at 20 weeks (30.2 + 3.4 vs. 13.4 + 2.4,
mean ± SEM), for preparation B at 19 weeks (9.6 +
0.8 vs. ± 4.5 + 0.9, mean + SEM) and for preparation
C at 12 weeks (10 + 1.7 vs. 3.2 ± 1.1, mean + SEM),
were all significantly different (p < 0.01) by the t-test.
There was no evidence that treatment with the modu-
lator produced toxicity. SENCAR mice were used for
preparation A. The amount of modulator preparation
tested in this experiment was not precisely quantified,
but each mouse was treated with an amount of modu-
lator equivalent to that derived from 500 g ground beef
(using the Preparation A extraction system). Papillo-
mas were evident at 6-7 weeks but were not system-
atically quantified untilweek 10 as indicated. One group
of five mice treated with modulator alone (no DMBA)
followed by TPA had no tumors at 20 weeks. Although
the numberofpapillomas permouse appears nottohave
plateaued by week 20, the respective means at 18 and
20 weeks for the control mice were not significantly
different (p > 0.2) by the t-test. This was also true for
the modulator-treated mice. In B, SENCAR mice were
used. Modulator preparation B was applied at 20 mg/
mouse representing an amount derived from 20 g
ground beef using this extraction system. Four modu-
lator-treated mice that had not developed tumors at
week 19 (termination of experiment) were retained; as
of this writing (week 42) two of these mice were still
tumor-free. In C, CD-1 mice were used, and it was
therefore necessary to increase the DMBA dose. For
this reason the modulator dose was also increased to 45
mg/mouse. Of the 20 modulator-treated mice, 10 were
treated with modulator 5 min. prior to DMBA and 10
were treated 30 min prior to DMBA (controls received
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acetone alone according to this schedule). The group
receivingthemodulator 5 mmn. priortoDMBAappeared
to be more inhibited but this has not yetbeen confirmed
in other experiments and for this reason, the results
from the two treatment times were combined in cal-
culating the data for Figure 2.
The data of Figure 2B are particularly interesting,
since each modulator-treated mouse was treated with
20 mg ofpreparation B which, by extrapolation (6) was
derived from only 20 g of ground beef (weight prior to
frying).
Previously we reported (4,5) that the modulator
seems to act in part through a direct effect on micro-
somal enzymes although the nature ofthis hypothetical
interaction is not yet known. Very recently we found
thatthemodulatorinhibitsthemetabolism of3H-DMBA
by rat liver microsomes (Table 1). Further, liver mi-
crosomalpreparations fromuntreated orphenobarbital-
treated rats were much more sensitive to inhibition by
the modulator than were microsomes from 3-methyl-
cholanthrene-treated rats. Interestingly the formation
of the DMBA-3,4-diol (a precursor to the ultimate car-
cinogenic bay region diol epoxide) was substantially
more sensitive to inhibition than was formation ofother
metabolites, suggesting that the modulator acts selec-
tively on certain forms ofcytochrome P-450 and notably
on form(s) producing high levels of the 3,4-diol (Table
1).
Role of Net Energy in Enhancement
of Carcinogenesis by Dietary Fat
The possibility that net energy might be involved in
the enhancement of carcinogenesis by dietary fat was
first proposed by Boutwell et al. (12). Using data gen-
erated by Forbes and co-workers (13-16), Boutwell et
al. (12) concluded that the enhancement of epidermal
carcinogenesis by dietary fat could be accounted for by
the more efficient utilization offat calories, as compared
with calories from carbohydrates. One may imagine the
followingmodel: food energy enters the body, and some
of it is retained primarily through the synthesis of fat
and protein. The rest is lost from the animal as heat or
in excreta. Forbes and co-workers (13-16) established
that as the amount of fat in the diet increases, the
amount of energy lost as heat decreases. The result is
a net gain in energy retained per unit of energy intake
within the carcass of the animal, as protein and/or fat.
It should also be recognized in this context that body
weight gain is not synonymous with body energy ac-
cumulation (17). For example, a heavier, muscular rat
may contain less energy than a lighter fat rat.
The molecular basis for the increased efficiency of
utilization offat is not understood, but is has been con-
firmed in many species of animals, including fowl (18).
It is due in part to the need to synthesize fat from
carbohydrate under conditions of low dietary fat (13-
16), and fat also increases intestinal transit time which
may permit greater absorption of nutrients (18).
The conclusions of Boutwell et al. (12), while intel-
lectually provocative, were not widely appreciated or
accepted apparently due in part to criticism by Silver-
stone and Tannenbaum (19). The criticism centered on
the interpretation of that part of the diet that should
be considered necessary for maintenance of body func-
tions, and that part that should be considered supple-
mental and available for energy gain. However, the
enhancement observed by Boutwell et al. (12) over that
which could be accounted forby calories alone was quite
small (20) and hence was consistent with either the
interpretation ofBoutwell et al. (12) or Silverstone and
Tannenbaum (19).
Given the uncertainties surrounding this issue, we
have undertaken a re-examination of the effect of rel-
ative net energy in terms of the enhancement of car-
Table 1. Effects of the modulator (preparation B) on metabolism of [3H]DMBA by liver microsomes from untreated rats (control) and
rats pretreated with phenobarbital (PB-induced) and 3-methylcholanthrene (MC-induced).
Liver DMBA metabolite, pmole/mg/minab
microsomes 5,6-Diol 8,9-Diol 3,4-Diol 7HOMMBAC 12HOMMBAC Totald
Control
-modulator 30 39 11 57 25 265
+modulator 15 (50) 23 (41) 3 (73) 31 (46) 21 (16) 125 (53)
PB-induced
-modulator 178 149 50 133 228 980
+modulator 76 (57) 79 (47) 11 (78) 91 (32) 200 (12) 540 (45)
MC-induced
-modulator 204 1410 NDe 580 ND 2700
+modulator 184 (10) 1040 (26) ND 440 (24) ND 2050 (24)
aSpecific activities for all metabolites were determined at 0-30 min for control microsomes, 0-10 min for PB-induced, and 0-5 min for MC-
induced microsomes, using the HPLC procedure of Cristou et al. (11).
bValues in parentheses denote percent inhibition.
c7 HOMMBA: 7-hydroxymethyl-12-methylbenz[a]anthracene 12 HOMMBA: 12-hydroxymethyl-7-methylbenz[a]anthracene.
dIncludes phenols and polyoxygenated products.
dND, below limits of detection.
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Table 2. Effect of dietary relative net energy value (NEV) on
breast tumor incidence.a b
20 weeks post-DMBA
Average daily intake Body Tumor
Diet g/day kcal/day RNE weight, g incidence Yield
HF 7.9 ± 0.6 40.7 1.06 226 ± 17c 73% (9/15) 2.4
LF 11.0 ± 0.9 42.5 1.00 203 ± 15 43% (6/14) 1.2
HFPF 6.8 ± 0.7 34.8 0.91 198 ± 13 7% (1/14) 1.0
aWeanling female F344 rats were obtained from a commercial sup-
plier and fed ad libitum a refined diet (20) containing 5% corn oil
(LF). At 52 days of age they were given a single dose of DMBA (65
mg/kg) by stomach tube and divided into three groups. One group
was continued on the LF diet, and a second group was fed ad libitum
a diet containing 30% corn oil (HF). The concentrations of protein,
vitamins, minerals, and fiber were balanced to account for differences
in the caloric densities ofthe diets. The third group ofrats was given
the HF diet, but pair-fed to the LF group in terms of net energy as
determined using the interpretation ofBoutwell et al. (12) ofthe data
of Forbes and coworkers (13-16) (HFPF group). Note the direct re-
lationship between RNE and tumor incidence.
bData from Boissoneault et al. (21).
Different from LF and HFPF groups (p < 0.05).
cinogenesis by dietary fat.
The results obtained in a recent experiment, sum-
marized in Table 2, demonstrate that the low fat (LF)
group exhibited greater food intake in terms ofgrams/
day and kilocalories/day than did the high fat (HF)
group. However, whencorrectedforrelativenetenergy
value (RNE) as interpreted by Boutwell et al. (12), it
was apparent that the HF group consumed more net
energy, which is also consistent with the fact that the
HF group exhibited greater body weight. The food in-
take ofthehigh-fatpair-fed (HFPF) groupwaslessthan
what was offered and for this reason the HFPF group
consumed less netenergythanthe LF group. However,
the body weights of the LF and HFPF groups were
virtually identical. The tumor incidence and yield was
in the order HF > LF > HFPF. Notably, there was a
direct relationship between tumor incidence and RNE
of the diet. Tumor incidence did not correlate with
either food intake (kcal/day) or body weight.
Discussion
Modulators of carcinogenesis in the diet may be rel-
evant to human health through either inhibition or en-
hancement of neoplasia (2,3). This report is focused on
two modulators actively studied in this laboratory: a
mutagenesis modulator frombeefthatinhibits initiation
of mouse epidermal tumors by DMBA, and the role of
net energy in the enhancement of carcinogenesis by
dietary fat.
To our knowledge, this is the first report on an an-
ticarcinogenic activity associated with beef. Inhibitors
of carcinogenesis have been reported in other foods,
notably edible plants, and arepostulated tomitigatethe
potentially deleterious effects oflow levels ofmutagens
and carcinogens that are ingested with food on a daily
basis (2,3). Modulator-mediated inhibition of carcino-
genic activity is ofgreat importance in view ofthe fact
that a number of PAH carcinogens, such as
benzo(a)pyrene, may be found in beef cooked under
some conditions (1). Case-control epidemiologic inves-
tigations of the possible association of beef and other
meats with cancers ofthe colon-rectum and breast are
at present unclear (22). One might speculate that the
modulator reported herein can act to moderate the ef-
fects of low levels of carcinogens that may be present
in cooked beef, leading to epidemiologic findings that
are equivocal.
The role ofnet energy in the enhancement ofcarcin-
ogenesis by dietary fat has broader public health im-
plications. For example, the public is currently being
advised to lower the amount offat in the diet, from 40-
42% to 30% of total calories (23). This advice is based
in part on the assumption that the quantity of dietary
fat per se is critical in tumor enhancement. However,
our data indicate that rats can consume a high fat diet
and yet develop fewer tumors than rats fed a low fat
diet.
The key seems to be restriction ofnet energy intake
rather than fat or even calories per se. Reinforcement
of this suggestion based on further experimental evi-
dence may alter the way that we think about dietary
fat and carcinogenesis and, ultimately, the advice that
is given to the public.
NOTE ADDED IN PROOF: The data shown in Table 1 were obtained
using preparations that had not been purified by chromatography.
More recent experiments with material ofgreater purity indicate that
the modulator inhibits all forms of cytochrome P-450.
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